Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteinuria and hypertension

E Ritz1, M Nowicki, D Fliser

  • 1Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany.

Kidney International. Supplement
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal Enhanced and Critical Care (MEaCC) in Yorkshire and the Humber: regional implementation of an enhanced maternal care pathway and data collection.

International journal of obstetric anesthesia·2024
Same author

Current perspectives on maternity critical care.

Anaesthesia·2023
Same author

Sugar or salt ("SOS"): A protocol for a UK multicentre randomised trial of mannitol and hypertonic saline in severe traumatic brain injury and intracranial hypertension.

Journal of the Intensive Care Society·2022
Same author

Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients: A systematic review.

Journal of internal medicine·2021
Same author

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.

BMC medicine·2020
Same author

[Chronic kidney disease-a cardiovascular high-risk constellation].

Der Internist·2019
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Albuminuria, or protein in urine, is common in hypertension and predicts organ damage and cardiovascular risk. It also appears in some normotensive individuals, suggesting complex links to hypertension and insulin resistance.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Albuminuria is more common in primary hypertension than in normotensive individuals.
  • Albuminuria presence indicates severe target organ damage and cardiovascular event risk.
  • Preliminary findings suggest albuminuria in normotensive individuals with genetic hypertension risk and insulin resistance.

Purpose of the Study:

  • To investigate the prevalence and significance of albuminuria in primary hypertension.
  • To explore the association of albuminuria with target organ damage and cardiovascular events.
  • To understand the role of albuminuria in normotensive individuals and its relation to hypertension etiology.

Main Methods:

  • Observational study comparing albuminuria in hypertensive and normotensive populations.

Related Experiment Videos

  • Analysis of associations between albuminuria, target organ damage, and cardiovascular events.
  • Evaluation of albuminuria in specific subgroups, including young patients and those with insulin resistance.

    • Main Results:

    • Albuminuria is a significant predictor of target organ damage and cardiovascular events.
    • Albuminuria is observed in young patients with mild to moderate primary hypertension.
    • Albuminuria is present in some normotensive individuals, particularly those with genetic hypertension risk or insulin resistance.
    • Antihypertensive treatment reduces albuminuria, with varying effects among different agents.

    Conclusions:

    • Albuminuria is a key marker in primary hypertension, linked to adverse outcomes.
    • The presence of albuminuria in normotensive individuals warrants further investigation into its role in hypertension.
    • Albuminuria's predictive value for hypertensive renal damage requires additional research.
    • Pharmacological interventions targeting albuminuria show promise, but agent-specific effects need clarification.